Alberta Cancer Foundation
STAR RATINGCi's Star Rating is calculated based on the following independent metrics: |
✔+
FINANCIAL TRANSPARENCY
Audited financial statements for current and previous years available on the charity’s website.
B
RESULTS REPORTING
Grade based on the charity's public reporting of the work it does and the results it achieves.
n/r
DEMONSTRATED IMPACT
The demonstrated impact per dollar Ci calculates from available program information.
NEED FOR FUNDING
Charity's cash and investments (funding reserves) relative to how much it spends on programs in most recent year.
79%
CENTS TO THE CAUSE
For a dollar donated, after overhead costs of fundraising and admin/management (excluding surplus) 79 cents are available for programs.
My anchor
OVERVIEW
About Alberta Cancer Foundation:
Alberta Cancer Foundation is a 3-star charity. It has below average disclosure with a B results reporting grade. It holds reserves outside of Ci’s reasonable range. For every dollar donated to Alberta Cancer Foundation, 79 cents are available to go to the cause.
Founded in 1985, the Alberta Cancer Foundation (ACF) is the fundraising partner for all 17 of Alberta's cancer centres, raising money to support cancer research and patient care across the province.
The charity reports that every year, more than 24,000 Albertans are diagnosed with cancer. One in two Albertans will develop the disease in their lifetime, and one in five will die from it. Diagnosis rates are projected to rise by 29% by 2030 and 56% by 2040
ACF runs two main programs: Research and Clinical Trials, and Patient Support.
The charity distributed $55.5m in grants in F2025 ($27.6m in F2024). In F2025, the three largest grants (accounting for 70% of total grants) were to Alberta Health Services ($24.2m), University of Alberta ($10.0m), and University of Calgary ($4.8m).
Research and Clinical Trials is ACF’s largest program, accounting for 64% of total grant disbursements in F2025. ACF funds cancer research and clinical trials across Alberta, supporting investigator-led studies and emerging treatment technologies. In F2025, 72 new clinical trials launched, bringing active trials to 221 provincewide. Last year, 972 Albertans participated in a cancer clinical trial. Notable funded research includes a made-in-Alberta CAR T-cell therapy trial, which treated 27 Albertans, and radiopharmaceutical work that produced new cancer-targeting isotopes including Lead-203.
Patient Support accounted for 36% of total grant disbursements in F2025. This program consists of 4 subprograms: Cancer Centre Infrastructure and Patient Care; Cancer Patient Navigation Program; Patient Financial Assistance Program; and Patient Experience. In F2025, over 63,000 patients were cared for at Alberta's cancer centres. ACF's navigation program connected 7,619 patients with support services through 25,410 navigator visits. Of these patients, 43% lived in rural communities. Through the Patient Financial Assistance Program, Albertans from 141 communities received help covering treatment-related costs. ACF's mobile breast screening program has delivered over 500,000 mammograms since inception, reaching more than 120 rural and Indigenous communities.
My anchor
Results and Impact
ACF reports that every dollar invested in clinical trials saves the healthcare system $14.
In F2025, the CAR T-cell clinical trial treated 27 Albertans, with 74% seeing a significant reduction in cancer cells and 60% remaining in remission for more than six months. The healthcare system saved over $400,000 per patient enrolled in the trial.
Alberta has seen an 8.7% increase in cancer survival rates, the most significant improvement compared to all other provinces.
ACF's mobile breast screening program has detected more than 3,000 breast cancers since inception. When detected early, the five-year survival rate for breast cancer is 93%, and over 80% of breast cancers detected through the program are found at an early stage.
While Ci highlights these key results, they may not be a complete representation of Alberta Cancer Foundation's results and impact. Alberta Cancer Foundation is not yet rated on impact (n/r). This does not affect its star rating.
My anchor
Finances
In F2025, ACF earned $124.8m in revenue. It received $86.5m in donations (69% of total revenue), $35.3m in investment income (28% of total revenue), and $3.0m in net lottery revenue (2% of total revenue). Donations increased 79% from F2023 and 292% from F2022. This growth is partly driven by the OWN.CANCER campaign, which aims to raise $250m for a comprehensive cancer care centre in Calgary.
Administrative costs are 7% of revenues (excluding investment income). Fundraising costs are 14% of donations. This results in total overhead spending of 21%. For every dollar donated to ACF, 79 cents are available to go to the cause. This falls within Ci’s reasonable range for overhead spending.
ACF's audited financial statements do not report grants separate from in-house program spending. As such, Ci reported all mission spending as grants. In F2025, ACF spent $55.5m on its grants, which is 44% of its revenue. This is a 101% increase from F2024.
ACF recorded a $50.7m surplus and spent $1.1m on capital projects.
Alberta Cancer Foundation has $303.8m in reserve funds. Excluding $89.4m in donor-endowed funds, the net funding reserves can cover 420%, or roughly four years and two months of program costs.
ACF has total investments of $287.4m. 40% is in cash and cash equivalents, 40% in equities, and 20% in bonds. In F2025, the annual return on investment for ACF was 13%. Its four-year annual return on investment is 14%.
ACF’s multi-year research grant commitments total to $58.4m over the next five years: $28.3m in F2026, $9.9m in F2027, $6.1m in F2028, $3.8m in F2029, and $10.3m in F2030.
In F2025, ACF reports $12.3m in total fundraising costs. Its T3010 lists $118.8m paid to external fundraisers, which exceeds total fundraising spend. We assume this is a typo.
This charity update has been sent to Alberta Cancer Foundation for review. Changes and edits may be forthcoming. Updated by Nick Reszetnik on June 25, 2026.
Financial Review
Fiscal year ending March
|
2025 | 2024 | 2023 |
|---|---|---|---|
| Administrative costs as % of revenues | 7.1% | 6.2% | 10.4% |
| Fundraising costs as % of donations | 14.3% | 10.8% | 18.2% |
| Total overhead spending | 21.3% | 17.0% | 28.6% |
| Program cost coverage (%) | 420.1% | 766.5% | 586.7% |
Summary Financial StatementsAll figures in $000s |
2025 | 2024 | 2023 |
|---|---|---|---|
| Donations | 86,453 | 85,425 | 48,371 |
| Lotteries (net) | 3,034 | 3,603 | 966 |
| Investment income | 35,348 | 20,927 | (5,187) |
| Other income | 1 | 12 | 17 |
| Total revenues | 124,837 | 109,966 | 44,167 |
| Grants | 55,496 | 27,593 | 27,157 |
| Administrative costs | 6,323 | 5,522 | 5,133 |
| Fundraising costs | 12,336 | 9,255 | 8,786 |
| Total spending | 74,155 | 42,370 | 41,077 |
| Cash flow from operations | 50,682 | 67,596 | 3,091 |
| Capital spending | 1,150 | 240 | 276 |
| Funding reserves | 303,765 | 265,222 | 201,743 |
Note: 1. LOTTERIES: Ci reports lotteries net of expenses. This affected total revenue and expenses by ($7.2m) in F2025, ($6.9m) in F2024, and ($7.4m) in F2023. 2. UNREALIZED GAIN (LOSS): Ci included unrealized gain (loss) in investment income. This affected total revenue by $1.0m in F2025, $10.0m in F2024, and ($3.3m) in F2023. 3. CHANGE IN PLEDGES RECEIVABLE: Ci adjusted for changes in pledges receivable. This affected revenue by $25.8m in F2025, ($27.1m) in F2024, and $513k in F2023. 4. DEFERRED ADJUSTMENT: ACF uses deferred accounting. To show donors information on a consistent basis, Ci adjusted for these deferred revenues. This affected revenues by ($423k) in F2025, $440k in F2024, and $28k in F2023. 5. CHANGE IN AMOUNTS DUE TO AHS: Ci adjusted for changes in amounts due to Alberta Health Services. This affected total expenses by ($11k) in F2025, $31k in F2024, and $198k in F2023.
Salary Information
$350k + |
0 |
$300k - $350k |
1 |
$250k - $300k |
0 |
$200k - $250k |
3 |
$160k - $200k |
2 |
$120k - $160k |
4 |
$80k - $120k |
0 |
$40k - $80k |
0 |
< $40k |
0 |
Information from most recent CRA Charities Directorate filings for F2025



My anchor
Comments & Contact
Comments added by the Charity:
Charity Contact
This email address is being protected from spambots. You need JavaScript enabled to view it. Tel: 780-643-4400